• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵清蛋白纳米载体对胰岛素的肿胀控制释放研究

An Investigation of Swelling Controlled Delivery of Insulin from Egg Albumin Nanocarriers.

作者信息

Mahobia Swati, Bajpai Jaya, Bajpai Anil Kumar

机构信息

Bose Memorial Research Laboratory, Department of Chemistry, Government Autonomous, Science College Jabalpur, (M.P.) - 482001 India.

出版信息

Iran J Pharm Res. 2016 Fall;15(4):695-711.

PMID:28243266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5316248/
Abstract

The aim of the present work was to prepare and characterize biopolymer nanocarriers and evaluate their suitability in possible oral delivery of insulin. The egg albumin biopolymer was used to prepare nanoparticles which were further characterized by Fourier transformed Infrared spectroscopy (FTIR), transmission electron microscopy (TEM), scanning electron microscopy (SEM), zeta potential, Dynamic Light scattering (DLS) and cytotoxicity. From the characterization studies the size of the nanoparticles washemoly found to lie in the range 20-80 nm with surface charge of -23 mV and also offering extremely fair biocompatibility.. The biocompatibility of the prepared nanocarriers was judged by BSA adsorption test and haemolysis assay. The in vitro release kinetics of the insulin loaded nanoparticles was studied in phosphate buffer saline (PBS) solution, and the influence of various factors such as pH, temperature and simulated physiological fluids was studied on the controlled release of insulin.

摘要

本研究的目的是制备和表征生物聚合物纳米载体,并评估其在胰岛素口服给药方面的适用性。使用卵清蛋白生物聚合物制备纳米颗粒,并用傅里叶变换红外光谱(FTIR)、透射电子显微镜(TEM)、扫描电子显微镜(SEM)、zeta电位、动态光散射(DLS)和细胞毒性对其进行进一步表征。通过表征研究发现,纳米颗粒的尺寸在20-80nm范围内,表面电荷为-23mV,并且具有非常良好的生物相容性。通过牛血清白蛋白吸附试验和溶血试验来判断所制备纳米载体的生物相容性。在磷酸盐缓冲盐水(PBS)溶液中研究了负载胰岛素的纳米颗粒的体外释放动力学,并研究了pH、温度和模拟生理流体等各种因素对胰岛素控释的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/4ef3bd1620f7/ijpr-15-695-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/aa812bcdabef/ijpr-15-695-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/5af3ea396753/ijpr-15-695-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/55a14a7c202f/ijpr-15-695-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/23fab627adbf/ijpr-15-695-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/b5ec84c5a5e6/ijpr-15-695-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/4ef3bd1620f7/ijpr-15-695-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/aa812bcdabef/ijpr-15-695-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/5af3ea396753/ijpr-15-695-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/55a14a7c202f/ijpr-15-695-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/23fab627adbf/ijpr-15-695-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/b5ec84c5a5e6/ijpr-15-695-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfb/5316248/4ef3bd1620f7/ijpr-15-695-g008.jpg

相似文献

1
An Investigation of Swelling Controlled Delivery of Insulin from Egg Albumin Nanocarriers.卵清蛋白纳米载体对胰岛素的肿胀控制释放研究
Iran J Pharm Res. 2016 Fall;15(4):695-711.
2
Single-Dose Electrospun Nanoparticles-in-Nanofibers Wound Dressings with Enhanced Epithelialization, Collagen Deposition, and Granulation Properties.单剂量电纺纳米纤维中的纳米粒子创伤敷料,具有增强的上皮化、胶原沉积和肉芽组织生成特性。
ACS Appl Mater Interfaces. 2016 Jun 15;8(23):14453-69. doi: 10.1021/acsami.6b04369. Epub 2016 Jun 1.
3
In Vitro Interaction of Doxorubicin-Loaded Silk Sericin Nanocarriers with MCF-7 Breast Cancer Cells Leads to DNA Damage.载有阿霉素的丝胶纳米载体与MCF-7乳腺癌细胞的体外相互作用导致DNA损伤。
Polymers (Basel). 2021 Jun 22;13(13):2047. doi: 10.3390/polym13132047.
4
Optimizing the release process and modelling of in vitro release data of cis-dichlorodiamminoplatinum (II) encapsulated into poly(2-hydroxyethyl methacrylate) nanocarriers.优化顺二氯二氨合铂(II)包裹于聚(甲基丙烯酸2-羟乙酯)纳米载体中的释放过程及体外释放数据建模。
Mater Sci Eng C Mater Biol Appl. 2016 Jan 1;58:852-62. doi: 10.1016/j.msec.2015.09.043. Epub 2015 Sep 12.
5
Synthesis and characterization of bovine serum albumin-coated copper sulfide nanoparticles as curcumin nanocarriers.牛血清白蛋白包覆的硫化铜纳米颗粒作为姜黄素纳米载体的合成与表征
Heliyon. 2023 Feb 14;9(2):e13740. doi: 10.1016/j.heliyon.2023.e13740. eCollection 2023 Feb.
6
Enhancement in Oral Absorption of Ceftriaxone by Highly Functionalized Magnetic Iron Oxide Nanoparticles.高功能化磁性氧化铁纳米颗粒增强头孢曲松的口服吸收
Pharmaceutics. 2020 May 28;12(6):492. doi: 10.3390/pharmaceutics12060492.
7
Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.具有对恶性A549肺肿瘤多治疗功效的载去甲氧基姜黄素壳聚糖-抗体核壳纳米颗粒:从体外表征到体内评估
Mol Pharm. 2015 Apr 6;12(4):1242-9. doi: 10.1021/mp500747w. Epub 2015 Mar 19.
8
Designing casein-coated iron oxide nanostructures (CCIONPs) as superparamagnetic core-shell carriers for magnetic drug targeting.设计酪蛋白包被的氧化铁纳米结构(CCIONPs)作为用于磁性药物靶向的超顺磁性核壳载体。
Prog Biomater. 2015 Mar;4(1):39-53. doi: 10.1007/s40204-014-0035-6. Epub 2014 Dec 19.
9
Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods.采用尺寸测量和原位光谱方法研究血清白蛋白蛋白在金纳米粒子上的吸附和构象。
Langmuir. 2011 Mar 15;27(6):2464-77. doi: 10.1021/la104124d. Epub 2011 Feb 22.
10
Genipin-modified gelatin nanocarriers as swelling controlled drug delivery system for in vitro release of cytarabine.栀子苷修饰明胶纳米载体作为膨胀控制的药物传递系统用于阿糖胞苷的体外释放。
Mater Sci Eng C Mater Biol Appl. 2016 Apr 1;61:457-65. doi: 10.1016/j.msec.2015.12.085. Epub 2015 Dec 30.

引用本文的文献

1
Zinc nanoparticles mitigate azoxystrobin and its nanoencapsulation-induced hepatic and renal toxicity in rats.锌纳米颗粒减轻大鼠中嘧菌酯及其纳米包封物诱导的肝毒性和肾毒性。
Redox Rep. 2025 Dec;30(1):2491318. doi: 10.1080/13510002.2025.2491318. Epub 2025 Apr 20.
2
The efficacy of egg albumin nanoparticles adjuvanted Clostridium perfringens type D toxoid vaccine in rabbits.卵清蛋白纳米颗粒佐剂产气荚膜梭菌D型类毒素疫苗对家兔的效力
Braz J Microbiol. 2025 Mar;56(1):665-674. doi: 10.1007/s42770-024-01589-3. Epub 2024 Dec 27.
3
Antidiabetic, anti-inflammatory, antioxidant, and cytotoxicity potentials of green-synthesized zinc oxide nanoparticles using the aqueous extract of .

本文引用的文献

1
Toxicity of nanomaterials.纳米材料的毒性。
Chem Soc Rev. 2012 Mar 21;41(6):2323-43. doi: 10.1039/c1cs15188f. Epub 2011 Dec 14.
2
Release dynamics of ciprofloxacin from swellable nanocarriers of poly(2-hydroxyethyl methacrylate): an in vitro study.可溶胀聚(甲基丙烯酸羟乙酯)纳米载体中环丙沙星的释放动力学:体外研究。
Nanomedicine. 2010 Jun;6(3):453-62. doi: 10.1016/j.nano.2009.11.006. Epub 2010 Jan 4.
3
Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation.通过胃肠道摄取和转运改善胰岛素纳米颗粒口服给药的策略。
使用……水提取物绿色合成的氧化锌纳米颗粒的抗糖尿病、抗炎、抗氧化和细胞毒性潜力
3 Biotech. 2024 Dec;14(12):291. doi: 10.1007/s13205-024-04125-0. Epub 2024 Nov 4.
4
Enhanced Targeted Delivery of Minocycline via Transferrin Conjugated Albumin Nanoparticle Improves Neuroprotection in a Blast Traumatic Brain Injury Model.通过转铁蛋白偶联白蛋白纳米颗粒增强米诺环素的靶向递送可改善爆炸创伤性脑损伤模型中的神经保护作用。
Brain Sci. 2023 Feb 25;13(3):402. doi: 10.3390/brainsci13030402.
5
Redox-Mediated Gold Nanoparticles with Glucose Oxidase and Egg White Proteins for Printed Biosensors and Biofuel Cells.基于氧化还原介导的金纳米粒子、葡萄糖氧化酶和蛋清蛋白的用于打印生物传感器和生物燃料电池。
Int J Mol Sci. 2023 Feb 28;24(5):4657. doi: 10.3390/ijms24054657.
6
Effect of minocycline and its nano-formulation on central auditory system in blast-induced hearing loss rat model.米诺环素及其纳米制剂对爆震性听力损失大鼠模型中枢听觉系统的影响。
J Otol. 2023 Jan;18(1):38-48. doi: 10.1016/j.joto.2022.09.002. Epub 2022 Oct 4.
7
Synthesis of Artemether-Loaded Albumin Nanoparticles and Measurement of Their Anti-Cancer Effects.载蒿甲醚白蛋白纳米粒的合成及其抗癌效果的测定
Biomedicines. 2022 Oct 26;10(11):2713. doi: 10.3390/biomedicines10112713.
8
Temperature-Responsive Polysaccharide Microparticles Containing Nanoparticles: Release of Multiple Cationic/Anionic Compounds.含纳米颗粒的温度响应性多糖微粒:多种阳离子/阴离子化合物的释放
Materials (Basel). 2022 Jul 5;15(13):4717. doi: 10.3390/ma15134717.
9
Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment.基于壳聚糖纳米粒子的系统:一种用于肺癌治疗的有前途的控释系统的新见解。
Molecules. 2022 Jan 12;27(2):473. doi: 10.3390/molecules27020473.
10
The Development of the Innovative Synthesis Methodology of Albumin Nanoparticles Supported by Their Physicochemical, Cytotoxic and Hemolytic Evaluation.基于理化性质、细胞毒性和溶血评估的白蛋白纳米粒创新合成方法的发展
Materials (Basel). 2021 Aug 5;14(16):4386. doi: 10.3390/ma14164386.
BioDrugs. 2008;22(4):223-37. doi: 10.2165/00063030-200822040-00002.
4
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.白蛋白作为药物载体:前药、药物偶联物及纳米颗粒的设计
J Control Release. 2008 Dec 18;132(3):171-83. doi: 10.1016/j.jconrel.2008.05.010. Epub 2008 May 17.
5
Current challenges in non-invasive insulin delivery systems: a comparative review.非侵入性胰岛素给药系统的当前挑战:一项比较综述。
Adv Drug Deliv Rev. 2007 Dec 22;59(15):1521-46. doi: 10.1016/j.addr.2007.08.019. Epub 2007 Aug 22.
6
Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.肝素从可膨胀交联淀粉微球中的控释动力学。
J Mater Sci Mater Med. 2007 Aug;18(8):1613-21. doi: 10.1007/s10856-007-3020-y. Epub 2007 May 5.
7
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.纳米颗粒作为蛋白质和疫苗潜在的口服给药系统:一种机制性方法。
J Control Release. 2006 Nov;116(1):1-27. doi: 10.1016/j.jconrel.2006.08.013. Epub 2006 Aug 23.
8
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.凝集素修饰的固体脂质纳米粒作为胰岛素口服给药的载体
Int J Pharm. 2006 Dec 11;327(1-2):153-9. doi: 10.1016/j.ijpharm.2006.07.026. Epub 2006 Jul 21.
9
Structural basis of the drug-binding specificity of human serum albumin.人血清白蛋白药物结合特异性的结构基础。
J Mol Biol. 2005 Oct 14;353(1):38-52. doi: 10.1016/j.jmb.2005.07.075.
10
Nanocapsule technology: a review.纳米胶囊技术综述
Crit Rev Ther Drug Carrier Syst. 2002;19(2):99-134. doi: 10.1615/critrevtherdrugcarriersyst.v19.i2.10.